Cargando…

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI)

Unilateral axillary lymphadenopathy is a frequent mild side effect of COVID-19 vaccination. European Society of Breast Imaging (EUSOBI) proposes ten recommendations to standardise its management and reduce unnecessary additional imaging and invasive procedures: (1) in patients with previous history...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiaffino, Simone, Pinker, Katja, Magni, Veronica, Cozzi, Andrea, Athanasiou, Alexandra, Baltzer, Pascal A. T., Camps Herrero, Julia, Clauser, Paola, Fallenberg, Eva M., Forrai, Gábor, Fuchsjäger, Michael H., Helbich, Thomas H., Kilburn-Toppin, Fleur, Kuhl, Christiane K., Lesaru, Mihai, Mann, Ritse M., Panizza, Pietro, Pediconi, Federica, Pijnappel, Ruud M., Sella, Tamar, Thomassin-Naggara, Isabelle, Zackrisson, Sophia, Gilbert, Fiona J., Sardanelli, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Guideline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378785/ https://www.ncbi.nlm.nih.gov/pubmed/34417642 http://dx.doi.org/10.1186/s13244-021-01062-x

Ejemplares similares

European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision
por: Schiaffino, Simone, et al.
Publicado: (2023)

Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
por: Mann, Ritse M., et al.
Publicado: (2022)

Breast MRI: EUSOBI recommendations for women’s information
por: Mann, Ritse M., et al.
Publicado: (2015)

Mammography: an update of the EUSOBI recommendations on information for women
por: Sardanelli, Francesco, et al.
Publicado: (2016)

Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging
por: Bick, Ulrich, et al.
Publicado: (2020)

A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice
por: Clauser, Paola, et al.
Publicado: (2017)

Mammography: EUSOBI recommendations for women’s information
por: Sardanelli, Francesco, et al.
Publicado: (2011)

Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging
por: Evans, Andrew, et al.
Publicado: (2018)

Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group
por: Baltzer, Pascal, et al.
Publicado: (2019)

A survey by the European Society of Breast Imaging on radiologists’ preferences regarding quality assurance measures of image interpretation in screening and diagnostic mammography
por: Michalopoulou, Eleni, et al.
Publicado: (2023)

Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey
por: Sardanelli, Francesco, et al.
Publicado: (2016)

Breast arterial calcifications as a biomarker of cardiovascular risk: radiologists’ awareness, reporting, and action. A survey among the EUSOBI members
por: Trimboli, Rubina Manuela, et al.
Publicado: (2020)

Virtual Touch IQ elastography reduces unnecessary breast biopsies by applying quantitative “rule-in” and “rule-out” threshold values
por: Kapetas, Panagiotis, et al.
Publicado: (2018)

A Simple Ultrasound Based Classification Algorithm Allows Differentiation of Benign from Malignant Breast Lesions by Using Only Quantitative Parameters
por: Kapetas, Panagiotis, et al.
Publicado: (2018)

Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)

Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI
por: Sodano, Claudia, et al.
Publicado: (2020)

An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies
por: Pötsch, Nina, et al.
Publicado: (2021)

AI-enhanced simultaneous multiparametric (18)F-FDG PET/MRI for accurate breast cancer diagnosis
por: Romeo, V., et al.
Publicado: (2021)

Simultaneous 18F-FDG PET/MRI Radiomics and Machine Learning Analysis of the Primary Breast Tumor for the Preoperative Prediction of Axillary Lymph Node Status in Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2023)

Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI
por: Wengert, G. J., et al.
Publicado: (2019)

Non-Invasive Assessment of Hypoxia and Neovascularization with MRI for Identification of Aggressive Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2020)

A Simultaneous Multiparametric (18)F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2022)

Inter- and intra-observer agreement of BI-RADS-based subjective visual estimation of amount of fibroglandular breast tissue with magnetic resonance imaging: comparison to automated quantitative assessment
por: Wengert, G. J., et al.
Publicado: (2016)

PB.40: Clinical recall audit: are we following national guidelines?
por: Kilburn-Toppin, F, et al.
Publicado: (2013)

Density and tailored breast cancer screening: practice and prediction – an overview
por: Wengert, Georg J, et al.
Publicado: (2018)

Sequential [(18)F]FDG-[(18)F]FMISO PET and Multiparametric MRI at 3T for Insights into Breast Cancer Heterogeneity and Correlation with Patient Outcomes: First Clinical Experience
por: Andrzejewski, Piotr, et al.
Publicado: (2019)

Introduction of a breast apparent diffusion coefficient category system (ADC-B) derived from a large multicenter MRI database
por: Bickel, Hubert, et al.
Publicado: (2023)

Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM
por: Pediconi, Federica, et al.
Publicado: (2020)

Visceral adipose tissue area predicts intensive care unit admission in COVID-19 patients
por: Pediconi, Federica, et al.
Publicado: (2021)

Bilateral lymphadenopathies on mammograms: a case of mixed connective tissue disease and psoriatic arthropathy
por: Giambersio, Emilia, et al.
Publicado: (2023)

Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis
por: Fueger, Barbara J., et al.
Publicado: (2021)

Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment
por: Wengert, Georg J., et al.
Publicado: (2019)

Nipple discharge: The state of the art
por: Panzironi, Giovanna, et al.
Publicado: (2018)

Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study
por: Rodriguez-Ruiz, Alejandro, et al.
Publicado: (2019)

Diffusion‐Weighted MRI of Breast Cancer: Improved Lesion Visibility and Image Quality Using Synthetic b‐Values
por: Bickel, Hubert, et al.
Publicado: (2019)

Is the Level of Contrast Enhancement on Contrast-Enhanced Mammography (CEM) Associated with the Presence and Biological Aggressiveness of Breast Cancer?
por: Marzogi, Alaa, et al.
Publicado: (2023)

Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI
por: Avendano, Daly, et al.
Publicado: (2019)

Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
por: Clauser, Paola, et al.
Publicado: (2020)

One view or two views for wide-angle tomosynthesis with synthetic mammography in the assessment setting?
por: Clauser, Paola, et al.
Publicado: (2021)

The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams
por: Milos, Ruxandra Iulia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_228tel9h16s46foo93hegviq19